ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nebraska » Interventional Cardiology

Top Interventional Cardiology Prescribers in Nebraska

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DANIEL MCGOWAN M.D.

Interventional Cardiology

14,512

$707K

893
816 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $48

AHMED KUTTY MD

Interventional Cardiology

9,679

$455K

606
551 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $48

SEAN DENNEY MD

Interventional Cardiology

9,636

$388K

792
728 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $48

AZARIAH KIRUBAKARAN M.D.

Interventional Cardiology

9,228

$506K

574
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $48

HAYSAM AKKAD MD

Interventional Cardiology

8,623

$435K

825
693 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $48

HARPAUL BAJWA MD

Interventional Cardiology

5,626

$195K

613
553 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $48

ERICH FRUEHLING M.D.

Interventional Cardiology

5,564

$283K

597
535 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $48

CLYDE MECKEL MD

Interventional Cardiology

5,039

$261K

506
455 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $48

DOUGLAS NETZ MD

Interventional Cardiology

4,932

$201K

485
437 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $48

RYAN WHITNEY M.D.

Interventional Cardiology

4,721

$256K

479
427 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $48

DOUGLAS KOSMICKI M.D.

Interventional Cardiology

4,404

$219K

489
443 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $48

DENES KORPAS MD

Interventional Cardiology

4,055

$207K

502
449 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $48

TIMOTHY GARDNER MD

Interventional Cardiology

3,688

$200K

391
333 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $48

JOSEPH JARZOBSKI M.D.

Interventional Cardiology

3,450

$214K

290
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $48

STEVEN MARTIN MD

Interventional Cardiology

3,284

$139K

461
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $48

STEPHEN O'CONNOR M.D.

Interventional Cardiology

3,136

$142K

281
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $48

RICHARD MARKIEWICZ MD

Interventional Cardiology

2,629

$88.9K

328
283 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 23%

$34
Average prescription price

Avg: $48

PANAYOTIS-ALAIN EFSTRATIOU MD

Interventional Cardiology

2,563

$164K

334
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $48

SHANNON HOOS THOMPSON M.D.

Interventional Cardiology

2,168

$76.5K

337
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $48

JEFFREY CARSTENS MD

Interventional Cardiology

2,133

$134K

187
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $48

SCOTT CAROLLO M.D.

Interventional Cardiology

1,974

$82.1K

207
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $48

DENNIS TIERNEY M.D.

Interventional Cardiology

1,891

$96.6K

235
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $48

IYAD AZZAM MD

Interventional Cardiology

1,640

$65.2K

280
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $48

HIMANSHU AGARWAL MD

Interventional Cardiology

1,209

$65.1K

148
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $48

ANN NARMI M.D.

Interventional Cardiology

987

$53.3K

159
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $48

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank